Clinical TrialsSearch results
Number of results: 616
Recruiting
- Sodium zirconium cyclosilicate non-Inferiority on hyperkalemia (Level of serum potassium) VErsus potassium Restricted diet in Subjects with type 2 diabetes mellitus; multicenter, open-label, randomized controlled, Two-Arm Research
- type 2 diabetes mellitus, hyperkalemia
- Hamaguchi Masahide
- 2023-07-11
Recruiting
- Living donor liver transplantation for non-resectable colorectal liver metastases
- non-resectable colorectal liver metastases
- Hatano Etsuro
- 2023-06-25
Recruiting
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
- Hidradenitis Suppurativa
- Ueda Eiji
- 2023-06-21
Other
- The safety and efficacy of ALARM-TD-V1 for sleep-disordered breathing
- Obstructive Sleep Apnea Syndrome
- Sato Susumu
- 2023-06-08
Recruiting
- How can we apply EEG neurofeedback (feeding back information on how strong brain regions are connected) to therapy for schizophrenia?
- Schizophrenia and other psychotic disorder or schizophrenia spectrum disorder
- Yoshihara Yujiro
- 2023-05-30
Recruiting
- Prospective observational study of castration-resistant prostate cancer with homologous recombination repair-related gene mutations.
- prostate cancer
- Goto Takayuki
- 2023-05-23
Recruiting
- Comparison of postoperative patient satisfaction using robot-assisted TKA with reference to knee alignment or ligament balance
- Medial knee osteoarthritis
- Kuriyama Shinichi
- 2023-04-13
Other
- A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab Monotherapy in Moderate-to-severe AD
- Atopic Dermatitis
- Chen Sarah
- 2023-04-03
Recruiting
- Study of brain activity changes by electrical stimulation on scalp and rehabilitation
- Central Nervous System Diseases
- Koganemaru Satoko
- 2023-03-17
Recruiting
- Double-blind, randomized, controlled trial of EIM-001 for in patients with Fontaine classification IIb lower extremity atherosclerosis obliterans
- atherosclerosis obliterans
- Takao Kato
- 2023-02-28